Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Osteoporosis Drugs Global Market Opportunities And Strategies To 2034

Osteoporosis Drugs Market 2025 – By Type (Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors, Parathyroid Hormone Therapy, Calcitonin, Sclerostin Inhibitor, Other Drug Class), By Administration (Oral, Injectable), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Sales), By Application (Primary Osteoporosis, Secondary Osteoporosis), And By Region, Opportunities And Strategies – Global Forecast To 2035

Osteoporosis Drugs Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 | Pages : 317 | Published : March 2025 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Osteoporosis Drugs Market Definition

Osteoporosis drugs are medications designed to prevent, treat, or manage osteoporosis—a condition characterized by decreased bone density and increased susceptibility to fractures. The primary goal of these medications is to strengthen bones, reduce bone loss and lower the risk of fractures.

The osteoporosis drugs market consists of sales, by entities (organizations, sole traders, or partnerships), of osteoporosis drugs that are primarily used by individuals diagnosed with osteoporosis, including postmenopausal women, older adults and patients undergoing treatments that affect bone density, such as long-term corticosteroid therapy.

Osteoporosis Drugs Market Size

The global osteoporosis drugs market reached a value of nearly $12,885.89 million in 2024, having grown at a compound annual growth rate (CAGR) of 2.42% since 2019. The market is expected to grow from $12,885.89 million in 2024 to $15,695.68 million in 2029 at a rate of 4.02%. The market is then expected to grow at a CAGR of 4.77% from 2029 and reach $19,809.27 million in 2034.  

Growth in the historic period resulted from the health insurance expansion, increase in bone fractures and comorbidities and government and health initiatives. Factors that negatively affected growth in the historic period were safety concerns.

Going forward, increasing aging population, rising healthcare expenditure, economic growth in emerging markets and rising prevalence of osteoporosis will drive the growth. Factor that could hinder the growth of the osteoporosis market in the future include high costs.  

Osteoporosis Drugs Market Drivers

The key drivers of the osteoporosis drugs market include:

Rising Healthcare Expenditure

During the forecast period, the rising healthcare expenditure are expected to propel the growth of the osteoporosis drugs market. Increased healthcare spending enhances R&D efforts for osteoporosis treatments, enabling pharmaceutical companies to develop more effective and innovative drugs. Increased healthcare spending enhances access to medical services, diagnostic tools and treatments, driving earlier diagnoses and improved management of osteoporosis. This boost in patient care raises demand for osteoporosis medications. For instance, according to the economic forecast from the Office for Budget Responsibility (OBR) and Treasury, planned health spending in the UK is expected to rise to £192 billion ($244.43 billion) in 2024/25 from £182 billion ($231.70 billion) in 2022/23.  Additionally, according to National Health Expenditures Accounts (NHEA) by KFF, a US-based independent source for health policy research, polling and journalism, health spending in the USA is expected to rise by 5% from 2023 to 2024, reaching $4.9 trillion.  Therefore, the rising healthcare expenditure will drive the growth of the osteoporosis drugs market.

Osteoporosis Drugs Market Restraints

The key restraints on the osteoporosis drugs market include:

High Cost Of Treatment

The high cost of treatment is expected to hinder the osteoporosis drugs market during the forecast period. Osteoporosis medications, particularly newer and more effective options, are often expensive, posing access challenges for patients, especially in regions with limited insurance coverage. Healthcare systems and insurers evaluate cost-effectiveness, potentially limiting reimbursement or increasing co-pays if drug costs outweigh perceived health benefits. This can discourage both patient uptake and provider adoption. For example, according to the National Center for Biotechnology Information, a US-based company advances science and health by providing access to biomedical and genomic information, each year in USA, osteoporosis-related bone fractures cost patients, their families and healthcare system approximately USD 19 billion. Experts estimate that by 2025, osteoporosis will be responsible for three million fractures, costing USD 25.3 billion.   Therefore, the high cost of treatment will restrain the growth of the osteoporosis drugs market.

Osteoporosis Drugs Market Trends

Major trends shaping the osteoporosis drugs market include:

Innovative Osteoporosis Treatment Launched To Enhance Patient Outcomes

Major companies operating in the osteoporosis drugs market are focusing on developing innovative solutions, such as teriparatide Injection for the treatment of treatment osteoporosis to enhance treatment outcomes. Teriparatide is a synthetic form of parathyroid hormone that stimulates bone growth, making it particularly effective for patients with severe osteoporosis or those at high risk of fractures. In November 2023, Apotex Corp, a Canada-based pharmaceutical corporation, launched Teriparatide Injection in the United States, a new treatment for osteoporosis available in a single-patient-use pre-filled pen containing 250 mcg/mL of teriparatide, allowing for 28 daily doses of 20 mcg. This launch addresses the needs of the approximately 10 million Americans affected by osteoporosis, providing an affordable option in the market. Developed in collaboration with Ambio, Inc., the product received FDA approval and reflects Apotex's commitment to enhancing patient access to essential medications.

Innovative Approaches And Regulatory Approvals Driving Treatment Advancements

Companies in the osteoporosis drugs market are prioritizing the development of innovative solutions, such as obtaining regulatory approvals to enhance treatment outcomes. Regulatory approvals refer to official authorization from health agencies, ensuring new treatments meet safety, efficacy and quality standards before market release. For instance, in November 2024, Teva Pharmaceuticals Inc., a US-based pharmaceutical company received U.S. Food and Drug Administration (FDA) approval for generic version of Forteo (teriparatide injection). This generic medication is recommended for postmenopausal women with osteoporosis at high fracture risk who are unable to use alternative treatments. It is also suitable for men with primary or hypogonadal osteoporosis under similar conditions. Additionally, it applies to both men and women experiencing osteoporosis due to long-term glucocorticoid use, again at high fracture risk and unable to use alternative therapies.

Opportunities And Recommendations In The Osteoporosis Drugs Market

Opportunities – The top opportunities in the osteoporosis drugs markets segmented by type will arise in the bisphosphonates segment, which will gain $1,074.11 million of global annual sales by 2029. The top opportunities in the osteoporosis drugs market segmented by administration will arise in the oral segment, which will gain $1,398.61 million of global annual sales by 2029. The top opportunities in the osteoporosis drugs markets segmented by distribution channel will arise in the retail pharmacies segment, which will gain $1,126.32 million of global annual sales by 2029. The top opportunities in the osteoporosis drugs markets segmented by application will arise in the primary osteoporosis segment, which will gain $2,246.06 million of global annual sales by 2029. The osteoporosis drugs market size will gain the most in USA at $870.53 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the osteoporosis drugs companies to focus on developing innovative and accessible treatment solutions, focus on regulatory approvals and innovative treatments, focus on enhancing medication adherence and targeted therapeutic options, focus on RANK ligand inhibitors for business growth, focus on the injectable segment for growth, expand in emerging markets, focus on expanding distribution channels for osteoporosis drugs, focus on developing competitive and flexible pricing strategies for osteoporosis drugs, focus on targeted marketing and educational campaigns for osteoporosis drugs, focus on physician engagement and influencer collaborations for osteoporosis drugs, focus on online sales for growth in osteoporosis drugs market and focus on primary osteoporosis market segment.

Book your 30 minutes free consultation with our research experts

Contact Us

Osteoporosis Drugs Market Segmentation

The osteoporosis drugs market is segmented by type, by administration, by distribution channel and by application.


By Type –


The osteoporosis drugs market is segmented by type into:

    • a) Bisphosphonates

    • b) Selective Estrogen Receptor Modulators (SERMs)

    • c) RANK Ligand Inhibitors

    • d) Parathyroid Hormone Therapy

    • e) Calcitonin

    • f) Sclerostin Inhibitor

    • g) Other Drug Class

The bisphosphonates market was the largest segment of the osteoporosis drugs market segmented by type, accounting for 34.45% or $4,438.84 million of the total in 2024. Going forward, the RANK ligand inhibitors segment is expected to be the fastest growing segment in the osteoporosis drugs market segmented by type, at a CAGR of 4.76% during 2024-2029.


By Administration –


The osteoporosis drugs market is segmented by administration into:

    • a) Oral

    • b) Injectable

The oral market was the largest segment of the osteoporosis drugs market segmented by administration, accounting for 57.71% or $7,436.18 million of the total in 2024. Going forward, the injectable segment is expected to be the fastest growing segment in the osteoporosis drugs market segmented by administration, at a CAGR of 4.71% during 2024-2029.


By Distribution Channel –


The osteoporosis drugs market is segmented by distribution channel into:

    • a) Retail Pharmacies

    • b) Hospital Pharmacies

    • c) Online Sales

The hospital pharmacies market was the largest segment of the osteoporosis drugs market segmented by distribution channel, accounting for 42.89% or $5,527.25 million of the total in 2024. Going forward, the retail pharmacies segment is expected to be the fastest growing segment in the osteoporosis drugs market segmented by distribution channel, at a CAGR of 4.50% during 2024-2029.


By Application –


The osteoporosis drugs market is segmented by application into:

    • a) Primary Osteoporosis

    • b) Secondary Osteoporosis

The primary osteoporosis market was the largest segment of the osteoporosis drugs market segmented by application, accounting for 78.19% or $10,075.43 million of the total in 2024. Going forward, the primary osteoporosis segment is expected to be the fastest growing segment in the osteoporosis drugs market segmented by application, at a CAGR of 4.11% during 2024-2029.


By Geography - The osteoporosis drugs market is segmented by geography into:

      o Asia Pacific

      • • China

      • • India

      • • Japan

      • • Australia

      • • Indonesia

      • • South Korea

      o North America

      • • USA

      • • Canada

      o South America

      • • Brazil

      o Western Europe

      • • France

      • • Germany

      • • UK

      • • Italy

      • • Spain

      o Eastern Europe

      • • Russia

      o Middle East

      o Africa

North America was the largest region in the osteoporosis drugs market, accounting for 43.50% or $5,605.74 million of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the osteoporosis drugs market will be Asia Pacific and South America where growth will be at CAGRs of 5.73% and 4.44% respectively. These will be followed by Eastern Europe and Western Europe where the markets are expected to grow at CAGRs of 4.25% and 3.58% respectively.

Osteoporosis Drugs Market Competitive Landscape

Major Competitors are:

  • Amgen Inc.

  • Eli Lilly and Company

  • Pfizer Inc.

  • Eisai Co., Ltd.

  • Apotex Inc.

    • Other Competitors Include:

  • AbbVie Inc.

  • Novartis AG

  • Sanofi S.A.

  • GSK plc

  • Daiichi Sankyo Company, Limited

  • Takeda Pharmaceutical Company

  • Teva Pharmaceuticals

  • Sun Pharmaceutical Industries Ltd.

  • Merck Sharp & Dohme

  • Roche Holding AG

  • Transcenta Holding Ltd.

  • Shanghai Henlius Biotech

  • Enzene Biosciences Ltd.

  • Eden Biologics

  • Zydus Lifesciences

  • Mabwell (Shanghai) Bioscience Co., Ltd.

  • Strides Pharma Science

  • Asahi Kasei Corporation

  • Pharmac

  • Axial Therapeutics

  • Acrux Limited

  • Cynata Therapeutics

  • Kyowa Kirin

  • Cadila Pharmaceuticals

  • Luye Pharma Group

  • Pharmed Limited

  • Chugai Pharmaceutical Co. Ltd.

  • Towa Pharmaceutical Co., Ltd.

  • GlaxoSmithKline plc

  • UCB S.A.

  • Sandoz AG

  • Enzene Biosciences Limited

  • Fresenius Kabi

  • Gedeon Richter

  • Alvotech

  • Mabxience Holding, S.L.

  • Theramex

  • Novo Nordisk A/S

  • Bristol Myers Squibb

  • Ferring Pharmaceuticals

  • Laboratoires Servier

  • Grunenthal GmbH

  • OsteoSys

  • Medimaps Group SA

  • Pharmanovia

  • Glenmark Pharmaceuticals

  • Dr. Max Group

  • Polpharma

  • Celon Pharma

  • Hasco-Lek

  • Biofarma S.A.

  • Mylan Pharmaceuticals

  • Radius Health, Inc.

  • Horizon Therapeutics

  • Levolta Pharmaceuticals, Inc.

  • Tabuk Pharmaceuticals

  • EVA Pharma

  • AstraZeneca

  • Abbott Laboratories

  • Adcock Ingram

  • Aspen Pharmacare Holdings Limited

  • IBN SINA Pharmaceutical

  • Solal Technologies

      • Table Of Contents

      1 Executive Summary

      1.1 Osteoporosis Drugs – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Osteoporosis Drugs Market Definition And Segmentations

      6.4 Market Segmentation By Type

      6.4.1 Bisphosphonates

      6.4.2 Selective Estrogen Receptor Modulators (SERMs)

      6.4.3 RANK Ligand Inhibitors

      6.4.4 Parathyroid Hormone Therapy

      6.4.5 Calcitonin

      6.4.6 Sclerostin Inhibitor

      6.4.7 Other Drug Class

      6.5 Market Segmentation By Administration

      6.5.1 Oral

      6.5.2 Injectable

      6.6 Market Segmentation By Distribution Channel

      6.6.1 Retail Pharmacies

      6.6.2 Hospital Pharmacies

      6.6.3 Online Sales

      6.7 Market Segmentation By Application

      6.7.1 Primary Osteoporosis

      6.7.2 Secondary Osteoporosis

      7 Major Market Trends

      7.1 Innovative Osteoporosis Treatment Launched To Enhance Patient Outcomes

      7.2 Innovative Approaches And Regulatory Approvals Driving Treatment Advancements

      7.3 Advance Treatment With Targeted Therapeutic Option For Better Osteoporosis Treatment

      8 Osteoporosis Drugs Market - Macro Economic Scenario

      8.1 COVID-19 Impact On The Osteoporosis Drugs Market

      8.2 Impact Of The War In Ukraine On The Osteoporosis Drugs Market

      8.3 Impact Of High Inflation On The Osteoporosis Drugs Market

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2019 – 2024, Value ($ Million)

      9.2.1 Market Drivers 2019 – 2024

      9.2.2 Market Restraints 2019 – 2024

      9.3 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

      9.3.1 Market Drivers 2024 – 2029

      9.3.2 Market Restraints 2024 – 2029

      10 Global Osteoporosis Drugs Market Segmentation

      10.1 Global Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.2 Global Osteoporosis Drugs Market, Segmentation By Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.3 Global Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.4 Global Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11 Osteoporosis Drugs Market, Regional and Country Analysis

      11.1 Global Osteoporosis Drugs Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.2 Global Osteoporosis Drugs Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia-Pacific Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.3 Asia-Pacific Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.4 Asia-Pacific Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.5 Asia-Pacific Osteoporosis Drugs Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 Market Information

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.9 China Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.10 China Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.11 India Market

      12.12 India Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.13 India Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.14 India Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.17 Japan Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.18 Japan Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.21 Australia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.22 Australia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.25 Indonesia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.26 Indonesia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.29 South Korea Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.30 South Korea Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate tax structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.3 Western Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.4 Western Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.5 Western Europe Osteoporosis Drugs Market: Country Analysis

      13.6 UK Market

      13.7 UK Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.8 UK Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.9 UK Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.12 Germany Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.13 Germany Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.14 France Market

      13.15 France Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.16 France Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.17 France Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.20 Italy Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.21 Italy Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.24 Spain Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.25 Spain Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Investments

      14.1.12 Major companies

      14.2 Eastern Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.3 Eastern Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.4 Eastern Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.5 Eastern Europe Osteoporosis Drugs Market: Country Analysis

      14.6 Russia Market

      14.7 Russia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.8 Russia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.9 Russia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.3 North America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.4 North America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.5 North America Osteoporosis Drugs Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.7 Regulatory Bodies

      15.7.8 Major Associations

      15.7.9 Taxes Levied

      15.7.10 Corporate Tax Structure

      15.7.11 Investments

      15.7.12 Major Companies

      15.8 USA Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.9 USA Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.10 USA Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.11 Canada Market

      15.12 Canada Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.13 Canada Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.14 Canada Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.3 South America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.4 South America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.5 Brazil Market

      16.6 Brazil Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.7 Brazil Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.8 Brazil Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Middle East Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.3 Middle East Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.4 Middle East Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.1.1 Market Overview

      18.1.2 Region Information

      18.1.3 Market Information

      18.1.4 Background Information

      18.1.5 Government Initiatives

      18.1.6 Regulations

      18.1.7 Regulatory Bodies

      18.1.8 Major Associations

      18.1.9 Taxes Levied

      18.1.10 Corporate Tax Structure

      18.1.11 Investments

      18.1.12 Major Companies

      18.2 Africa Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18.3 Africa Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18.4 Africa Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 Amgen Inc.

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Financial Overview

      19.3 Eli Lilly and Company

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Financial Overview

      19.4 Pfizer Inc.

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Financial Overview

      19.5 Eisai Co., Ltd.

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Financial Overview

      19.6 Apotex Inc.

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial Overview

      20 Other Major And Innovative Companies

      20.1 AbbVie Inc.

      20.1.1 Company Overview

      20.1.2 Products And Services

      20.2 Novartis AG

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.3 Sanofi S.A.

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.4 GSK plc

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.5 Daiichi Sankyo Company, Limited

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.6 F. Hoffmann La Roche Ltd.

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.7 Teva Pharmaceutical Industries Limited

      20.7.1 Company Overview

      20.7.2 Products And Services

      20.8 Merck & Co. Inc.

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.9 Radius Health, Inc.

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.10 Mylan N.V. (Viatris)

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.11 Sun Pharmaceutical Industries Ltd.

      20.11.1 Company Overview

      20.11.2 Products And Services

      20.12 UCB Biopharma SRL

      20.12.1 Company Overview

      20.12.2 Products And Services

      20.13 Dr. Reddy's Laboratories

      20.13.1 Company Overview

      20.13.2 Products And Services

      20.14 Strides Pharma Science Limited

      20.14.1 Company Overview

      20.14.2 Products And Services

      20.15 EffRx Pharmaceuticals SA

      20.15.1 Company Overview

      20.15.2 Products And Services

      21 Competitive Benchmarking

      22 Competitive Dashboard

      23 Key Mergers And Acquisitions

      23.1 Bone Health Technologies Acquired Wellen

      23.2 Nestlé Health Science Acquired Bountiful Company

      24 Opportunities And Strategies

      24.1 Global Osteoporosis Drugs Market In 2029 – Countries Offering Most New Opportunities

      24.2 Global Osteoporosis Drugs Market In 2029 – Segments Offering Most New Opportunities

      24.3 Global Osteoporosis Drugs Market In 2029 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 Osteoporosis Drugs Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Osteoporosis Drugs Market, Historic, 2019 – 2024, $ Million
    • Table 2: Global Osteoporosis Drugs Market, Forecast, 2024 – 2029, 2034F , $ Million
    • Table 3: Global Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 4: Global Osteoporosis Drugs Market, Segmentation By Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 5: Global Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 6: Global Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 7: Global Osteoporosis Drugs Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 8: Global Osteoporosis Drugs Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 9: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $
    • Table 10:  Asia-Pacific Population, By Country, 2019-2029, Millions
    • Table 11: Asia-Pacific Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 12: Asia-Pacific Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 13: Asia-Pacific Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 14: China GDP Per Capita, 2019-2024, $
    • Table 15:  China Population, 2019-2029, Millions
    • Table 16: China Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 17: China Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 18: China Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 19: India Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 20: India Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 21: India Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 22: Japan Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 23: Japan Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 24: Japan Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 25: Australia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 26: Australia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 27: Australia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 28: Indonesia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 29: Indonesia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 30: Indonesia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 31: South Korea Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 32: South Korea Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 33: South Korea Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 34: Western Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 35:  Western Europe Population, By Country, 2019-2029, Millions
    • Table 36: Western Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 37: Western Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 38: Western Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 39: UK Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 40: UK Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 41: UK Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 42: Germany Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 43: Germany Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 44: Germany Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 45: France Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 46: France Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 47: France Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 48: Italy Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 49: Italy Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 50: Italy Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 51: Spain Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 52: Spain Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 53: Spain Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 54: Eastern Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 55:  Eastern Europe Population, By Country, 2019-2029, Millions
    • Table 56: Eastern Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 57: Eastern Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 58: Eastern Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 59: Russia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 60: Russia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 61: Russia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 62: North America GDP Per Capita, By Country, 2019-2024, $
    • Table 63:  North America Population, By Country, 2019-2029, Millions
    • Table 64: North America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 65: North America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 66: North America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 67: USA GDP Per Capita, 2019-2024, $
    • Table 68:  USA Population, 2019-2029, Millions
    • Table 69: USA Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 70: USA Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 71: USA Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 72: Canada Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 73: Canada Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 74: Canada Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 75: South America GDP Per Capita, By Country, 2019-2024, $
    • Table 76:  South America Population, By Country, 2019-2029, Millions
    • Table 77: South America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 78: South America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 79: South America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 80: Brazil Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 81: Brazil Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 82: Brazil Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 83: Middle East GDP Per Capita, By Country, 2019-2024, $
    • Table 84:  Middle East Population, By Country, 2019-2029, Millions
    • Table 85: Middle East Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 86: Middle East Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 87: Middle East Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 88: Africa GDP Per Capita, By Country, 2019-2024, $
    • Table 89:  Africa Population, By Country, 2019-2029, Millions
    • Table 90: Africa Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 91: Africa Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 92: Africa Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 93: Global Osteoporosis Drugs Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Table 94: Amgen – Financial Overview, 2019 – 2023, $ Billion
    • Table 95: Eli Lilly and Company – Financial Overview, 2019 – 2023, $ Billion
    • Table 96: Pfizer Inc. – Financial Overview, 2019 – 2023, $Billion
    • Table 97: Eisai Co., Ltd. – Financial Overview, 2023, $ Billion
    • Table 98: Apotex Inc. – Financial Overview, 2023, $ Billion
    • Table 99: Osteoporosis Drugs Market, Competitive Benchmarking (In USD Millions)
    • Table 100: Osteoporosis Drugs Market, Competitive Dashboard
    • Table 101: Global Osteoporosis Drugs Market Size Gain ($ Million), 2024 – 2029, By Country
    • Table 102: Global Osteoporosis Drugs Market Size Gain ($ Million), Segmentation By Product Type, 2024 – 2029
    • Table 103: Global Osteoporosis Drugs Market Size Gain ($ Million), Segmentation By Administration, 2024 – 2029
    • Table 104: Global Osteoporosis Drugs Market Size Gain ($ Million), Segmentation By Distribution Channel, 2024 – 2029
    • Table 105: Global Osteoporosis Drugs Market Size Gain ($ Million), Segmentation By Application, 2024 – 2029
    • Table 106: Osteoporosis Drugs Market Data Sources

    List Of Figures

      Figure 1: Global Osteoporosis Drugs Market Segmentation By Type
    • Figure 2: Global Osteoporosis Drugs Market Segmentation By Administration
    • Figure 3: Global Osteoporosis Drugs Market Segmentation By Distribution Channel
    • Figure 4: Global Osteoporosis Drugs Market Segmentation By Application
    • Figure 5: Global Osteoporosis Drugs Market, Historic, 2019 – 2024, $ Million
    • Figure 6: Global Osteoporosis Drugs Market, Forecast, 2024 – 2029, 2034F, $ Million
    • Figure 7: Global Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 8: Global Osteoporosis Drugs Market, Segmentation By Administration, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 9: Global Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 10: Global Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 11: Global Osteoporosis Drugs Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 12: Global Osteoporosis Drugs Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 13: Asia-Pacific Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 14: Asia-Pacific Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 15: Asia-Pacific Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 16: China Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 17: China Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 18: China Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 19: India Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 20: India Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 21: India Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 22: Japan Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 23: Japan Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 24: Japan Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 25: Australia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 26: Australia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 27: Australia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 28: Indonesia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 29: Indonesia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 30: Indonesia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 31: South Korea Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 32: South Korea Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 33: South Korea Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 34: Western Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 35: Western Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 36: Western Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 37: UK Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 38: UK Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 39: UK Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 40: Germany Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 41: Germany Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 42: Germany Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 43: France Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 44: France Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 45: France Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 46: Italy Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 47: Italy Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 48: Italy Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 49: Spain Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 50: Spain Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 51: Spain Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 52: Eastern Europe Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 53: Eastern Europe Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 54: Eastern Europe Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 55: Russia Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 56: Russia Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 57: Russia Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 58: North America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 59: North America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 60: North America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 61: USA Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 62: USA Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 63: USA Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 64: Canada Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 65: Canada Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 66: Canada Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 67: South America Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 68: South America Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 69: South America Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 70: Brazil Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 71: Brazil Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 72: Brazil Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 73: Middle East Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 74: Middle East Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 75: Middle East Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 76: Africa Osteoporosis Drugs Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 77: Africa Osteoporosis Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 78: Africa Osteoporosis Drugs Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 79: Global Osteoporosis Drugs Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Figure 80: Amgen – Financial Overview, 2019 – 2023, $ Billion
    • Figure 81: Eli Lilly and Company – Financial Overview, 2019 – 2023, $ Billion
    • Figure 82: Pfizer Inc. – Financial Overview, 2019 – 2023, $ Billion
    • Figure 83: Geographic Regions Covered

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    Global Cancer Immunotherapy Market Overview And Prospects – Includes Cancer Immunotherapy Market Share

    Read More

    How Will The Biosimilar Interleukins Market Grow In 2022?

    Read More

    Latest Cancer Clinical Decision Tools Market Growth Study 2022-2026 By The Business Research Company

    Read More

    Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

    Read More

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine, Therapeutic Nutrients And Mineralsa) Cardiovascular Drugs Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti-Thrombotic, Angina Pectoris, Congestive Heart Failure, Other Cardiovascular Drugsb) Dermatology Drugs Type (Acne Drugs, Dermatitis Drugs, Psoriasis Drugs, Other Drugs For Dermatology Diseasesc) Gastrointestinal Drugs Type (Antacids, Antiulcerants, Antiemetics And Antinauseants, Antidiarrhealsd) Genito-Urinary Drugs Type (Hormonal Contraceptives, Drugs For Benign Prostatic Hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction

    View Report

    Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032

    View Report

    Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

    View Report

    Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

    View Report

    Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

    View Report